Pfizer Just Locked Next Growth Path: What Investors Should Know
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Explore ways to fund a business with no money. Unlock creative financing options and start your entrepreneurial journey now!
21,633 articlesPfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
U.S. markets climbed as Cisco impressed with earnings and Cerebras Systems began trading. The AI-driven rally helped ...
Investors weigh whether SanDisk can sustain its rally as datacenter demand and hyperscaler contracts provide longer-t...
Nvidia has expanded its stake in CoreWeave and is pursuing a broader AI infrastructure strategy that goes beyond chip...
Quantum names showed a broad pullback after a sharp rally, with IonQ down about 7% and D-Wave slipping near 8% as inv...
Guggenheim started coverage on StubHub with a Buy rating and a $12.50 price target, signaling optimism for the live-e...
Cisco and CrowdStrike rally prompt debate on which name makes the better short bet. The case centers on Cisco's margi...
Lowe's 2026 earnings outlook hinges on margin discipline and online growth. This guide breaks down what to watch and ...
Workday is set to report Q1 earnings after the close tonight, the first quarter under its returning CEO. Analysts foc...
Apple hits a fresh 52-week high as Services revenue climbs and iPhone demand remains strong. The move fuels a buy, ho...
Ford is mounting a renewed effort in a longtime European battleground. This article breaks down the plan, the pitfall...
A shift in AI hardware could redefine winners and losers in tech investing. Here’s how ASICs may outpace GPUs and whi...